Fortrea Holdings (FTRE) Current Leases (2022 - 2026)
Fortrea Holdings (FTRE) reported Current Leases of $8.8 million for Q1 2026, down 34.81% on a YoY basis from $13.5 million in Q1 2025, and down 4.35% quarter-over-quarter from $9.2 million in Q4 2025.
Fortrea Holdings (FTRE) Current Leases (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Current Leases for 5 years, with the latest figure at $8.8 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 34.81% year-over-year to $8.8 million; the trailing twelve-month figure through Mar 2026 stood at $8.8 million (down 34.81% YoY), and the FY2025 full-year result was $9.2 million, down 31.34% from the prior year.
- Current Leases for Q1 2026 stood at $8.8 million, down from $9.2 million in the prior quarter.
- The five-year high for Current Leases was $23.3 million in Q4 2022, with the low at $8.8 million in Q1 2026.
- Historically, Current Leases has averaged $14.6 million across 5 years, with a median of $13.5 million in 2024.
- Annual changes were most pronounced in 2025 — Current Leases slipped 8.15% — and 2026, when it slumped 34.81%.
- Fortrea Holdings' Current Leases stood at $23.3 million in 2022, then dropped by 26.18% to $17.2 million in 2023, then declined by 22.09% to $13.4 million in 2024, then plunged by 31.34% to $9.2 million in 2025, then fell by 4.35% to $8.8 million in 2026.
- The last three Current Leases figures came in at $8.8 million (Q1 2026), $9.2 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 8.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.80 Mn |
| Dec 31, 2025 | 9.20 Mn |
| Sep 30, 2025 | 9.20 Mn |
| Jun 30, 2025 | 12.40 Mn |
| Mar 31, 2025 | 13.50 Mn |
| Dec 31, 2024 | 13.40 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 13.50 Mn |
| Mar 31, 2024 | 15.20 Mn |
| Dec 31, 2023 | 17.20 Mn |
| Sep 30, 2023 | 19.60 Mn |
| Jun 30, 2023 | 20.20 Mn |
| Dec 31, 2022 | 23.30 Mn |